by Team Small News | Apr 25, 2025 | Pharma
A recent development in the pharmaceutical industry has led to a batch of Telma AM, a medication previously classified as Not of Standard Quality (NSQ), being flagged as spurious. This means that the batch in question has been deemed to be of inferior quality,... by Team Small News | Apr 25, 2025 | Alkem, Pharma
Alkem Laboratories, a leading pharmaceutical company, has successfully completed the acquisition of a 100% stake in Adroit Biomed, a biotechnology company. This strategic move is expected to strengthen Alkem’s presence in the biotechnology sector and expand its...
by Team Small News | Apr 25, 2025 | Pharma, Sun Pharma
Sun Pharmaceutical Industries and Moebius Medical have announced promising results from a Phase II clinical trial for their investigational osteoarthritis treatment, MM-II. The study demonstrated significant improvements in pain reduction and functional improvement in... by Team Small News | Apr 25, 2025 | Apollo Hospital, Pharma
A groundbreaking surgical procedure was successfully performed by Dr. Prashant Meshram, a renowned shoulder surgeon, at Apollo Hospitals in Jubilee Hills, Hyderabad. The 58-year-old patient had been suffering from chronic pain and significant weakness in his right... by Team Small News | Apr 24, 2025 | Aurobindo Pharma, Pharma
Aurobindo Pharma’s subsidiary, Eugia Pharma Specialities, has received final approval from the US Food and Drug Administration (FDA) to manufacture and market Dasatinib Tablets in various strengths. The approved product is bioequivalent and therapeutically... by Team Small News | Apr 24, 2025 | Lupin, Pharma
Lupin Ltd, a leading pharmaceutical company, has received approval from the US Food and Drug Administration (USFDA) for its generic version of Tolvaptan tablets. The tablets are indicated for the treatment of autosomal dominant polycystic kidney disease (ADPKD), a...